Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

8.40
+0.00280.03%
Volume:394.41K
Turnover:3.36M
Market Cap:576.72M
PE:-4.65
High:8.76
Open:8.34
Low:8.19
Close:8.40
52wk High:11.54
52wk Low:2.86
Shares:68.63M
Float Shares:39.65M
Volume Ratio:0.43
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8064
EPS(LYR):-2.2041
ROE:-59.22%
ROA:-34.41%
PB:1.88
PE(LYR):-3.81

Loading ...

Olema announces updated data on Phase 1b/2 study of palazestrant, ribociclib

TIPRANKS
·
Oct 20

Olema Reports Promising Phase 1b/2 Data for Palazestrant Plus Ribociclib in Advanced Breast Cancer

Reuters
·
Oct 18

Olema Oncology Announces New Data From the Phase 1B/2 Trial of Palazestrant Plus Ribociclib in Er+/Her2- Metastatic Breast Cancer at Esmo 2025

THOMSON REUTERS
·
Oct 18

Guggenheim Initiates Olema Pharmaceuticals at Buy With $20 Price Target

MT Newswires Live
·
Oct 08

Olema Pharmaceuticals (OLMA) Gets a Buy from Guggenheim

TIPRANKS
·
Oct 08

Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan

Reuters
·
Oct 03

Oppenheimer Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Sep 23

Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA

TIPRANKS
·
Sep 23

Olema Pharmaceuticals Grants Stock Options to New Employees Under 2022 Inducement Plan

Reuters
·
Sep 04

Olema Pharmaceuticals and Pfizer Announce New Clinical Trial for Novel Breast Cancer Drug Combination

Reuters
·
Sep 02

Olema- Under Agreement Pfizer to Supply Atirmociclib, Olema to Lead Study

THOMSON REUTERS
·
Sep 02

Olema Oncology Announces New Clinical Trial Agreement With Pfizer to Combine Palazestrant With Atirmociclib in Er+/Her2- Metastatic Breast Cancer

THOMSON REUTERS
·
Sep 02

Olema Pharmaceuticals Inc. to Participate in Citi's Biopharma Back to School Conference

Reuters
·
Aug 21

Olema Pharmaceuticals Inc : Citigroup Raises Target Price to $21 From $20

THOMSON REUTERS
·
Aug 12

U.S. RESEARCH ROUNDUP-Advanced Drainage Systems, Assurant, Chipotle Mexican Grill

Reuters
·
Aug 12

Olema Pharmaceuticals Inc : Jefferies Assumes Coverage With Buy Rating; Target Price $30

THOMSON REUTERS
·
Aug 12

Olema Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12

Olema Pharmaceuticals Q2 EPS $(0.51) Misses $(0.38) Estimate

Benzinga
·
Aug 12

Olema Pharmaceuticals Reports Increased Net Loss of $43.8 Million in Q2 2025 Due to Milestone Payment and R&D Expenses

Reuters
·
Aug 12

BRIEF-Olema Pharmaceuticals Q2 Net Income USD -43.784 Million

Reuters
·
Aug 12